Zobrazeno 1 - 1
of 1
pro vyhledávání: '"L V, Sequist"'
Autor:
J J, Lin, A, Muzikansky, E, Kennedy, H, Kuberski, L L, Stober, A C, Wanat, C G, Azzoli, I, Lennes, L V, Sequist, I, Dagogo-Jack, A T, Shaw, J F, Gainor
Publikováno v:
ESMO Open
Background Alectinib, a second-generation anaplastic lymphoma kinase (ALK) tyrosine kinase inhibitor (TKI), is highly effective in advanced ALK-rearranged non-small-cell lung cancer and represents a standard first-line therapy. New strategies are nee